How IL-9-secreting T cells can kill tumors more effectively
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
['FUNDING_R01'] · METHODIST HOSPITAL RESEARCH INSTITUTE · NIH-10892825
This study is looking at how a special type of immune cell, called IL-9-secreting CD8+ Tc9 cells, can help fight tumors in a new way, and it aims to find better treatments for cancer by using these cells to make tumors die more effectively.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | METHODIST HOSPITAL RESEARCH INSTITUTE (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10892825 on ClinicalTrials.gov |
What this research studies
This research investigates the role of a specific type of immune cell, known as IL-9-secreting CD8+ Tc9 cells, in fighting tumors. The researchers have found that these Tc9 cells can induce a unique form of cell death in tumors called pyroptosis, which is more effective than the traditional methods used by other immune cells. By understanding the mechanisms behind this enhanced tumor-killing ability, the research aims to develop new therapeutic strategies that harness the power of Tc9 cells to improve cancer treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with tumors that may respond to treatments involving immune cell therapies, particularly those involving CD8+ T cells.
Not a fit: Patients with tumors that do not express the necessary markers for Tc9 cell targeting or those who are not eligible for immune cell therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer therapies that utilize the body's immune system to eliminate tumors.
How similar studies have performed: Other research has shown promising results with similar immune cell therapies, indicating that this approach has potential for success.
Where this research is happening
HOUSTON, UNITED STATES
- METHODIST HOSPITAL RESEARCH INSTITUTE — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: YI, QING — METHODIST HOSPITAL RESEARCH INSTITUTE
- Study coordinator: YI, QING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.